No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.
We wrap a busy week in SPACs: deSPACs, DAs…and even some old fashioned rumor and speculation is back.
WIth the SEC’s new rules looming large, Citi says no more SPAC IPO underwriting for now. A SPAC IPO is offset by two withdrawals. And the rest of the day’s news in SPACs.
Citigroup (C) pauses underwriting new SPAC IPOs amidst the potential for incremental legal risks. Regulatory scrutiny and monetary tightening are likely to mean more pain for the stock market– including IPOs.
Deal announcements keep flowing with PAFO / Caravelle Group. NuScale gets PIPE financing. And the rest of the day’s news in SPACs.
Gogoro (GGR) deSPACs in the green. Black Rifle Coffee Company (BRCC) takes a hit on warrant redemption. And the rest of the day’s news in SPACs.
GGPI / Polestar revs on HTZ order. DWAC / Truth Social slammed by 2 executive departures and Elon’s TWTR stake. Two DAs! And the rest of the day’s news in SPACs.
GGPI shares are up 6% on an announced Polestar partnership with HTZ that includes purchasing up to 65,000 EVs over five years. We continue to view the shares as undervalued heading into the merger.
Ending the week with a bang: two SPAC IPOs, DA for VCXA, and merger approval for HLXA/ Immunotherapeutics AG.
Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.